Luma Group — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

ROME Therapeuticsrometx.comSep 2023

Boston-based biotech developing drugs against the 'dark genome'/repeatome for autoimmune disease, cancer and neurodegeneration.

Benjamin Greenbaum(Founder)David Ting(Founder)Rosana Kapeller(Founder)

Co-investorsAndreessen Horowitz ARCH Venture Partners GV (Google Ventures)Sanofi Ventures Abingworth Advent Life Sciences +11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.